Royalty Pharma PLC
F:RPD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Royalty Pharma PLC
F:RPD
|
US |
|
Sasol Ltd
NYSE:SSL
|
ZA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RPD's stock price target?
Price Target
35.28
EUR
According to Wall Street analysts, the average 1-year price target for 
RPD is 35.28 EUR with a low forecast of 24.534 EUR and a high forecast of 38.813 EUR.
What is the Revenue forecast for Royalty Pharma PLC?
Projected CAGR
18%
Over the last 7 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 18%.
What is the Operating Income forecast for Royalty Pharma PLC?
Projected CAGR
12%
Over the last 7 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 12%.
What is the Pre-Tax Income forecast for Royalty Pharma PLC?
Projected CAGR
38%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 3 years is 38%.
What is the Net Income forecast for Royalty Pharma PLC?
Projected CAGR
64%
Over the last 7 years, the compound annual growth rate for Net Income has been -8%. The projected CAGR for the next 3 years is 64%.